Why Analyst Sees Both Intel and Arm Winning With Big Opportunities
While Computex 2015 in Taipei was said to be less than impressive, Canaccord Genuity sees opportunities for Intel and Arm Holdings.
While Computex 2015 in Taipei was said to be less than impressive, Canaccord Genuity sees opportunities for Intel and Arm Holdings.
While Tesla is not necessarily a company looking to make quick moves or gains, it is looking to become a dominant player in batteries and electric cars in the next decade.
FIFA-backed "United Passions" took quite a beating at the box office over the past weekend.
A new research note from Cowen highlights the strength and gains from two technology titans that are obliterating the competition and are really pulling away from the pack.
Boeing has admitted -- sort of -- that the company will have to cut production of the current version of its 777 passenger plane in 2018 as it transitions to building the new 777X.
Ballard Power Systems announced that it has signed definitive license and supply agreements with both Nantong Zehe New Energy Technology and Guangdong Synergy Hydrogen Power Technology.
Investors looking for growth ideas may want to look away from momentum, and Jefferies has three very solid ideas for this week.
Monday's top analyst upgrades, downgrades and initiations include Exxon Mobil, Home Depot, Lululemon Athletica, 3M, Vodafone, Mondelez International and Chevron.
A recent report from UBS highlights technology stocks with the highest short interest to free float percentage, one of which is torching the short sellers now.
Sears Holdings reported mixed first-quarter 2015 results and announced REIT launch date before markets opened on Monday.
The president of Florida State University made $105,000 in the past year, as reported by The Chronicle of Higher Education. It seems like a lot of money.
Rains that flooded much of Texas have wiped out the drought in what may be an exceptionally short time.
This coming week is likely to be a serious one in the fight against cholesterol. FDA panels are evaluating more than just one drug candidate.
Huntington Ingalls Industries confirmed late in the week that it received a $3.35 billion contract award for the detail design and construction of the nuclear-powered aircraft carrier John F. Kennedy.
Another earnings season has come to a close, but a few companies are straggling behind the pack.